esorubicin has been researched along with Carcinoma, Anaplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbott, TM; Alberts, DS; Mason-Liddil, N; O'Toole, RV; Salmon, SE; Stock-Novack, D | 1 |
| Berman, ML; Blessing, JA; McGuire, WP | 1 |
| Falkson, G; Vorobiof, DA | 1 |
1 trial(s) available for esorubicin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
A phase II evaluation of esorubicin in ovarian cancer. A Southwest Oncology Group study.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma; Doxorubicin; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Ovarian Neoplasms; Survival Analysis; Treatment Outcome | 1992 |
2 other study(ies) available for esorubicin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma; Doxorubicin; Drug Evaluation; Drugs, Investigational; Female; Hematologic Diseases; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms | 1989 |
Phase II study of 4'-deoxydoxorubicin in advanced colorectal cancer.
Topics: Adult; Aged; Blood Cell Count; Bone Marrow; Carcinoma; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Humans; Middle Aged; Nausea; Rectal Neoplasms | 1986 |